| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/27/2008 | US7378407 Geldanamycin compounds and method of use |
| 05/27/2008 | US7378406 11 beta -(4-acetylphenyl)-17 beta-hydroxy-17-alpha-(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one or a derivative, especially for prophylaxis and treatmenet of breast cancer |
| 05/27/2008 | US7378405 Adding an omega-3 acid for stabilizing a formulation including hydrocortisone 17-butyrate |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | US7378402 4-Amino-1-((2R,3S,4S,5R)-5-azido-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one; hepatitis C virus. |
| 05/27/2008 | US7378401 Administering (5-fluorouridine)-5'-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt; actinic keratosis |
| 05/27/2008 | US7378400 Method to reduce an inflammatory response from arthritis |
| 05/27/2008 | US7378399 Avermectins substituted in the 4″ and 4′-positions having pesticidal properties |
| 05/27/2008 | US7378398 Administering a sulfoquinovosylacylglycerol; uterine cancer, breast cancer or pancreas adenocarcinoma cancer |
| 05/27/2008 | US7378397 Peptide derivatives; thyrotropin-releasing hormone-degrading; brain and spinal injuries, central nervous system disorders |
| 05/27/2008 | US7378388 Method of utilizing neurotrophins to manipulate reproductive capacity |
| 05/27/2008 | US7378387 Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes |
| 05/27/2008 | US7378386 inhibiting viral replication or infection by contacting a composition with a virally infected cell with a cell impervious cephalin-binding ligand or proteins; treating an animal with a viral infection; hepatitis, influenza, AIDS, viral pneumonia or respiratory disease |
| 05/27/2008 | US7378237 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/27/2008 | US7378111 Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease |
| 05/27/2008 | US7378108 Percutaneous absorption preparation of compound having angiotensin II antagonistic activity |
| 05/27/2008 | US7378107 administering triglycerides such as triester of caprylic acid or capric acid with glycerin, used along with foods or drugs, without concerning about side effects and restrictive diets |
| 05/27/2008 | US7378105 medical equipment comprising support structures including drug carriers or excipients and rapamycin derivatives or prodrugs, and taxol, used for reducing hyperplasia when implanted in vascular systems |
| 05/27/2008 | US7378102 Diclofenac sodium oral pharmaceutical |
| 05/27/2008 | US7378098 CXC chemokine receptor 4 agonist peptides |
| 05/27/2008 | US7378082 Method for treating allergic rhinitis without adverse effects |
| 05/27/2008 | US7378077 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/27/2008 | CA2575873A1 Spray mixture for soothing a cow udder |
| 05/27/2008 | CA2514473C Fused bicyclic nitrogen-containing heterocycles |
| 05/27/2008 | CA2455115C Pharmaceutical aerosol formulation |
| 05/27/2008 | CA2438170C Modulated release particles for aerosol delivery |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/27/2008 | CA2384111C Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 05/27/2008 | CA2379752C Use of agonists of gabab receptors and pharmaceutically acceptable derivates thereof, in the therapy of maintaining nicotine abstinence-dependent patients |
| 05/27/2008 | CA2345064C Fentanyl composition for the treatment of acute pain |
| 05/27/2008 | CA2272063C Antithrombotic organic nitrates |
| 05/27/2008 | CA2264895C Device and method for treating ophthalmic diseases |
| 05/27/2008 | CA2256960C High glycerin containing anti-microbial cleansers |
| 05/27/2008 | CA2145641C Pseudo-adenovirus vectors |
| 05/24/2008 | CA2610638A1 Use of agomelatine to obtain drugs intended for the treatment of smith-magenis syndrome |
| 05/22/2008 | WO2008061247A2 Benzenesulfonanilide compound inhibitors of urea transporters |
| 05/22/2008 | WO2008061238A2 Processes for production of 4-biphenylyazetidin-2-ones |
| 05/22/2008 | WO2008061236A2 Sulfoximines as kinase inhibitors |
| 05/22/2008 | WO2008061201A1 Methods for treating renal tumors using 2,4-pyrimidinediamine drug and prodrug compounds |
| 05/22/2008 | WO2008061189A1 C-9 alkenylidine bridged macrolides |
| 05/22/2008 | WO2008061160A1 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 05/22/2008 | WO2008061134A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer |
| 05/22/2008 | WO2008061109A2 Indazole derivatives useful as melanin concentrating receptor ligands |
| 05/22/2008 | WO2008061108A2 Phthalazine derivatives |
| 05/22/2008 | WO2008061078A2 Matrix-embedded compositions having organic acids and fatty acids |
| 05/22/2008 | WO2008061048A2 Methods and compositions for diagnosing and treating prostate cancer |
| 05/22/2008 | WO2008061029A1 Aryl sulfonamide derivatives and methods of their use |
| 05/22/2008 | WO2008061016A1 N-substituted piperidinyl 4 -arylsulfonamides as modulators of the secreted frizzled related protein- 1 |
| 05/22/2008 | WO2008061006A1 Substituted indan-2-yl, tetrahydronaphthalen-2-yl, or dihydr0-2h-chr0men-3-yl arylsulfonamides and methods of their use |
| 05/22/2008 | WO2008060999A1 Piperidinyl arylsulfone derivatives as modulators of secreted frizzled related protein-1 |
| 05/22/2008 | WO2008060998A1 Indole sulfonamides as sfrp-1 modulators |
| 05/22/2008 | WO2008060982A1 Methods for treating inflammatory conditions |
| 05/22/2008 | WO2008060964A2 Unit dosage package and methods for administering weight loss medications |
| 05/22/2008 | WO2008060963A2 Layered pharmaceutical formulations comprising an intermediate rapidly dissolving layer |
| 05/22/2008 | WO2008060949A2 Compounds with anti-androgenic activity and the use thereof |
| 05/22/2008 | WO2008060934A2 Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration |
| 05/22/2008 | WO2008060907A2 Pyrrolo-pyridine kinase inhibitors |
| 05/22/2008 | WO2008060890A2 Darusentan oral dosage form |
| 05/22/2008 | WO2008060866A1 Novel compounds |
| 05/22/2008 | WO2008060865A2 Compositions and methods for reducing antimicrobial resistance of microbes |
| 05/22/2008 | WO2008060837A2 Methods and compositions for the treatment of cancer |
| 05/22/2008 | WO2008060771A2 Pyrazole compounds |
| 05/22/2008 | WO2008060764A2 Topical therapies for oral mucositis and other conditions |
| 05/22/2008 | WO2008060721A1 Uses of selective inhibitors of hdac8 for treatment of t-cell proliferative disorders |
| 05/22/2008 | WO2008060693A2 Tetracyclic imidazole analogs |
| 05/22/2008 | WO2008060626A2 Compounds for modulating trpv3 function |
| 05/22/2008 | WO2008060622A2 Improved methods and compositions for wound healing |
| 05/22/2008 | WO2008060621A2 Aminopyrrolidines as chemokine receptor antagonists |
| 05/22/2008 | WO2008060609A1 Crystalline forms of ibandronate sodium |
| 05/22/2008 | WO2008060578A2 3-aryl-6-aryl-[1,2,4] triazolo[3,4-b][1,3,4] thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 05/22/2008 | WO2008060575A2 Drug delivery system and method |
| 05/22/2008 | WO2008060572A1 Use of gabapentin and pregabalin prodrugs for treating tinnitus |
| 05/22/2008 | WO2008060569A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 05/22/2008 | WO2008060567A1 Glycosaminoglycan formulations in the treatment of vascular disease |
| 05/22/2008 | WO2008060546A2 Oral formulations |
| 05/22/2008 | WO2008060488A1 Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/22/2008 | WO2008060476A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/22/2008 | WO2008060448A2 Small molecule pak inhibitors |
| 05/22/2008 | WO2008060441A2 Stable amifostine liquid concentrate |
| 05/22/2008 | WO2008060397A2 Method of treating thermoregulatory disfunction |
| 05/22/2008 | WO2008060381A2 Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivator |
| 05/22/2008 | WO2008060375A2 Upregulating bdnf levels to mitigate mental retardation |
| 05/22/2008 | WO2008060372A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/22/2008 | WO2008060332A2 Methods for treating or reducing muscle fatigue |
| 05/22/2008 | WO2008060301A1 7-substituted purine derivatives for immunosuppression |
| 05/22/2008 | WO2008060271A1 Sigma ligands for neuronal regeneration and functional recovery |
| 05/22/2008 | WO2008060269A2 Quinoline methanol compounds for the treatment and prevention of parasitic infections |
| 05/22/2008 | WO2008060248A1 Indole sustituted pyrimidines and use thereof in the treatment of cancer |
| 05/22/2008 | WO2008060240A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
| 05/22/2008 | WO2008060228A1 Extended release formulations comprising quetipine and methods for their manufacture |
| 05/22/2008 | WO2008060190A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 05/22/2008 | WO2008060112A1 Composition comprising araliae cordatae radix extract or compounds isolated from the same for preventing or treating periodontitis |
| 05/22/2008 | WO2008060056A1 External composition for skin containing manassantin b as active ingredient and the use thereof for skin whitening |
| 05/22/2008 | WO2008060051A1 Transnasal anticonvulsive pharmaceutical composition |
| 05/22/2008 | WO2008060002A1 Polyethylene glycol-g-csf conjugate |
| 05/22/2008 | WO2008059965A1 Agent for alleviating or preventing stress symptoms and agent for improving mental conditions |
| 05/22/2008 | WO2008059885A1 Gel-like sterilizing/disinfecting composition |
| 05/22/2008 | WO2008059869A1 Method of degrading polysaccharide |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |